EP0969790A2 - Compositions de traitement de l'acne rosacee - Google Patents

Compositions de traitement de l'acne rosacee

Info

Publication number
EP0969790A2
EP0969790A2 EP98913571A EP98913571A EP0969790A2 EP 0969790 A2 EP0969790 A2 EP 0969790A2 EP 98913571 A EP98913571 A EP 98913571A EP 98913571 A EP98913571 A EP 98913571A EP 0969790 A2 EP0969790 A2 EP 0969790A2
Authority
EP
European Patent Office
Prior art keywords
arginine
derivatives
preparations
group
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98913571A
Other languages
German (de)
English (en)
Inventor
Walter Diembeck
Udo Hoppe
Birgit Salzer
Gerhard Sauermann
Volker Steinkraus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19711565A external-priority patent/DE19711565A1/de
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of EP0969790A2 publication Critical patent/EP0969790A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Abstract

L'invention concerne l'utilisation, notamment l'utilisation topique, d'un ou plusieurs composés sélectionnés dans le groupe des inhibiteurs de la NO-synthase et de leurs dérivés pour la prophylaxie et/ou le traitement de l'acné rosacée et de la couperose.
EP98913571A 1997-02-21 1998-02-20 Compositions de traitement de l'acne rosacee Withdrawn EP0969790A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19706581 1997-02-21
DE19706581 1997-02-21
DE19711565 1997-03-20
DE19711565A DE19711565A1 (de) 1997-02-21 1997-03-20 Zubereitungen für die Behandlung von Rosacea
PCT/EP1998/000991 WO1998036730A2 (fr) 1997-02-21 1998-02-20 Compositions de traitement de l'acne rosacee

Publications (1)

Publication Number Publication Date
EP0969790A2 true EP0969790A2 (fr) 2000-01-12

Family

ID=26034114

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98913571A Withdrawn EP0969790A2 (fr) 1997-02-21 1998-02-20 Compositions de traitement de l'acne rosacee

Country Status (3)

Country Link
EP (1) EP0969790A2 (fr)
JP (1) JP2001512471A (fr)
WO (1) WO1998036730A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19918750A1 (de) * 1999-04-24 2000-10-26 Beiersdorf Ag Wirkstoffe, kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
FR2808189B1 (fr) * 2000-04-28 2004-03-05 Oreal Lipochroman-6 comme inhibiteur de no-synthase et utilisations
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
US20050020600A1 (en) 2003-07-23 2005-01-27 Scherer Warren J. Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
CN101010076B (zh) 2004-09-02 2010-06-09 克斯莫石油株式会社 健康功能改善剂
JP4814567B2 (ja) * 2004-09-02 2011-11-16 コスモ石油株式会社 健康機能向上剤
JP4814501B2 (ja) * 2004-09-02 2011-11-16 コスモ石油株式会社 抗酸化機能向上剤
JP4814568B2 (ja) * 2004-09-02 2011-11-16 コスモ石油株式会社 免疫機能向上剤
EP2091325B1 (fr) * 2006-10-12 2014-08-06 Topaz Pharmaceuticals Inc. Formulation shampooing-après-shampooing comprenant un avermectine pour l'élimination et la prophylaxie contre les souches de poux sensibles et résistantes aux traitements
EP2116237A1 (fr) * 2008-08-05 2009-11-11 Polichem SA Compositions pour traiter la rosacée comprenants du chitosane et un acide dicarboxylique
JP2011063541A (ja) * 2009-09-17 2011-03-31 Tokyo Institute Of Technology Ｌ−アルギニン結合因子の精製方法及びｌ−アルギニン様化合物のスクリーニング方法
EP2329849B1 (fr) 2009-11-18 2015-04-29 Galderma Research & Development Combinaison d'un agoniste du récepteur alpha-2 adrénergique et d'un agent anti-inflammatoire non stéroïdien pour traiter ou empêcher un trouble cutané inflammatoire
US8394800B2 (en) 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
KR20130010122A (ko) 2010-03-26 2013-01-25 갈데르마 리써어치 앤드 디벨로프먼트 모세혈관 확장증의 안전하고 유효한 치료를 위한 개선된 방법 및 조성물
CA2792646C (fr) 2010-03-26 2018-11-20 Galderma Research & Development Utilisations et compositions ameliorees pour un traitement sur et efficace de l'erytheme
US20130261126A1 (en) 2010-10-21 2013-10-03 Galderma S.A. Brimonidiine gel compositions and methods of use
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707494B1 (fr) * 1993-07-02 1995-08-25 Roussel Uclaf Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
FR2740339B1 (fr) * 1995-10-26 1997-12-05 Oreal Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
FR2744915B1 (fr) * 1996-02-16 1998-03-27 Oreal Composition cosmetique a base de cellules indifferenciees de ginkgo biloba

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9836730A2 *

Also Published As

Publication number Publication date
WO1998036730A2 (fr) 1998-08-27
JP2001512471A (ja) 2001-08-21
WO1998036730A3 (fr) 1998-10-22

Similar Documents

Publication Publication Date Title
EP0802783B1 (fr) Preparations a teneur en l-arginine a usage local
EP0633017B1 (fr) Compositions cosmétiques et dermatologiques contenant de l'acide delta-aminolevulinique
EP1296642B1 (fr) Utilisation de creatine et/ou de derives de creatine dans des preparations dermatologues
EP0969790A2 (fr) Compositions de traitement de l'acne rosacee
DE4341000A1 (de) Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen
DE4420625C1 (de) Wirkstoffkombination mit einem Gehalt an Glycerylalkylethern und kosmetische und dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend
EP0656774B1 (fr) Compositions cosmetiques et dermatologiques anti-solaires contenant des thiols et/ou des derives de thiol
EP1194115A1 (fr) Agent pour usage topique a action protectrice et regeneratrice, comprenant de l'idebenone
EP0686026B1 (fr) Combinaisons photoprotectrices synergiques et formulations cosmetiques et dermatologiques les contenant
WO2002009652A2 (fr) Utilisation d'associations contenant des carnitines
EP1813255B1 (fr) Combinaison active stable contenant des dérivés de glucose tensioactifs et des hydroxyacides
EP1324745A1 (fr) Preparations cosmetiques et dermatologiques contenant de l'aminoguanidine
WO1997009975A1 (fr) Preparations topiques efficaces contre le cancer de la peau
EP0586961B1 (fr) Formulations cosmétiques et dermatologiques contenant une teneur effective d'acide cis-urocanique
DE19711565A1 (de) Zubereitungen für die Behandlung von Rosacea
EP0656773B1 (fr) Utilisation de capteurs de radicaux comme agents immunomodulateurs dans des compositions cosmetiques et dermatologiques
DE19720339A1 (de) Wirkstoffe und Zubereitungen für die Hautaufhellung und zur Verhinderung der Hautbräunung
EP1084701A1 (fr) Emulsion H/E contenant un ou plusieurs bioquinones et un teneur de glycerine élevée
DE19806946A1 (de) Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
EP0945127A2 (fr) Utilisation de l'acylcarnitine
DE19545107A1 (de) Verwendung eines wirksamen Gehaltes an Adenosin in kosmetischen oder dermatologischen Zubereitungen
EP0747035A2 (fr) Composition pour le traitement des pellicules et pour le traitement des cheveux
DE10316666B4 (de) Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin mit Kreatin und Coenzym Q10
EP0771561A2 (fr) Compositions antimycotiques, particulièrement actives contre les pellicules contenant des alcools aromatiques
EP0955038A1 (fr) Compositions cosmétiques et dermatologiques contenant des céramides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990728

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE ES FR GB IT LI NL SE

17Q First examination report despatched

Effective date: 20030721

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050701